Assessment of clozapine taste in healthy volunteers: evidence for non-aversive sensory profile
Therapeutic Advances in Psychopharmacology · 2026-07 · 16
DOI: 10.1177/20451253261458524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 04.07.2026. Verfasst von Laura Modica de Mohac und 3 weiteren Autor:innen. Beteiligte Einrichtung: King's College London, School of Cancer and Pharmaceutical Sciences, Institute of Pharmaceutical Science, London, UK. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Acceptability is crucial for treatment efficacy, and the World Health Organization emphasizes its impact on patient compliance. Taste plays a significant role in acceptability, with bitter taste often leading to treatment discontinuation. Clozapine, an effective drug for treatment-resistant schizophrenia, faces acceptability challenges that have been connected to its poor taste.
Objectives
The aim of this study was to conduct, for the first time, a human taste assessment of clozapine to directly measure its level of aversiveness.
Design
Human volunteer study.
Methods
Employing a “swirl and spit” method, 23 young healthy adults rated the taste of four clozapine solutions (0.0011–0.018 mg/mL) on a visual analog scale (VAS) ranging from 0 (not aversive) to 100 mm (extremely aversive).
Results
Clozapine was not aversive at any concentrations, even at saturation: mean VAS scores ranged from 5.6 to 10.3/100 (median scores ranged between 2 and 4).
Conclusion
Reported barriers to compliance linked to taste aversiveness of marketed or extemporaneous dosage forms of clozapine may be linked to factors such as the dosage form itself, other negative formulation or excipients’ organoleptic characteristics, packaging, and user instructions linked to dosing frequency and duration, and of course, patient and disease-related factors, which require further investigations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King's College London, School of Cancer and Pharmaceutical Sciences, Institute of Pharmaceutical Science, London, UK.
- UCL School of Pharmacy, London, UK.
- Pharmacy Department, Maudsley Hospital, Denmark Hill, London SE5 8AZ, UK.
ORCID-Profile: David Taylor
Zitieren
APA
Modica de Mohac, L., Keeley, A., Taylor, D., & Tuleu, C. (2026). Assessment of clozapine taste in healthy volunteers: evidence for non-aversive sensory profile. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261458524
Vancouver
Modica de Mohac L, Keeley A, Taylor D, Tuleu C. Assessment of clozapine taste in healthy volunteers: evidence for non-aversive sensory profile. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261458524
BibTeX
@article{ModicadeMohac2026,
author = {Modica de Mohac, Laura and Keeley, Alex and Taylor, David and Tuleu, Catherine},
title = {Assessment of clozapine taste in healthy volunteers: evidence for non-aversive sensory profile},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261458524}
}
EUVIMED